Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare Part D

American Journal of Kidney Diseases

Volumn 64, Issue 1, 2014, Pages 95-103

  Yusuf, Akeem A ^a,b   Weinhandl, Eric D ^a   St Peter, Wendy L ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

calcium acetate; cardiovascular disease; comparative effectiveness; coronary calcification; dialysis; elderly; end stage renal disease (ESRD); hyperphosphatemia; Index Words; Medicare Part D; mortality; phosphate binders; sevelamer

Indexed keywords

CALCIUM ACETATE; CINACALCET; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEVELAMER; SEVELAMER CARBONATE; VITAMIN D;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; DAY HOSPITAL; DEATH; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PLEIOTROPY; PRESCRIPTION; PROPENSITY SCORE;

CALCIUM ACETATE; CARDIOVASCULAR DISEASE; COMPARATIVE EFFECTIVENESS; CORONARY CALCIFICATION; DIALYSIS; ELDERLY; END-STAGE RENAL DISEASE (ESRD); HYPERPHOSPHATEMIA; MEDICARE PART D; MORTALITY; PHOSPHATE BINDERS; SEVELAMER;

ACETATES; AGED; AGED, 80 AND OVER; CALCIUM COMPOUNDS; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MEDICARE PART D; POLYAMINES; RENAL DIALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84903265462     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.11.015     Document Type: Article

References (31)

1. A.J. Collins, R.N. Foley, and C. Herzog et al. US Renal Data System 2012 annual data report Am J Kidney Dis 61 1 suppl 1 2013 e1 e480
2. A.J. Bleyer, S.K. Burke, and M. Dillon et al. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients Am J Kidney Dis 33 4 1999 694 701
3. J.G. Hervas, D. Prados, and S. Cerezo Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate Kidney Int Suppl 85 2003 S69 S72
4. G.M. Chertow, S.K. Burke, and P. Raggi Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 1 2002 245 252
5. P. Raggi, J. Bommer, and G.M. Chertow Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer J Heart Valve Dis 13 1 2004 134 141
6. J. Braun, H.G. Asmus, and H. Holzer et al. Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification Clin Nephrol 62 2 2004 104 115
7. G.A. Block, D.M. Spiegel, and J. Ehrlich et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis Kidney Int 68 4 2005 1815 1824
8. G.M. Chertow, S.K. Burke, M.A. Dillon, and E. Slatopolsky Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients Nephrol Dial Transplant 14 12 1999 2907 2914
9. A.T. Peres, M.A. Dalboni, and M.E. Canziani et al. Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients Hemodial Int 13 3 2009 271 277
10. Y.F. Lin, C.T. Chien, and W.C. Kan et al. Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study Clin Drug Investig 31 4 2011 257 267
11. K. Caglar, M.I. Yilmaz, and M. Saglam et al. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients Clin J Am Soc Nephrol 3 1 2008 61 68
12. W.N. Suki, R. Zabaneh, and J.L. Cangiano et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 9 2007 1130 1137
13. G.A. Block, P. Raggi, A. Bellasi, L. Kooienga, and D.M. Spiegel Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients Kidney Int 71 5 2007 438 441
14. P.L. Hebert, L.S. Geiss, E.F. Tierney, M.M. Engelgau, B.P. Yawn, and A.M. McBean Identifying persons with diabetes using Medicare claims data Am J Med Qual 14 6 1999 270 277
15. A.M. McBean, S. Li, D.T. Gilbertson, and A.J. Collins Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians Diabetes Care 27 10 2004 2317 2324
16. T.M. Therneau, and P.M. Grambsch Multiple events per subject T.M. Therneau, P.M. Grambsch, Modeling Survival Data: Extending the Cox Model 2000 Springer-Verlag New York, NY 169 229
17. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1 1983 41 55
18. R.J. Glynn, S. Schneeweiss, and T. Sturmer Indications for propensity scores and review of their use in pharmacoepidemiology Basic Clin Pharmacol Toxicol 98 3 2006 253 259
19. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference. http://www2.sas.com/proceedings/sugi26/p214-26. pdf. Accessed April 29, 2013.
20. A.M. Peterson, D.P. Nau, J.A. Cramer, J. Benner, F. Gwadry-Sridhar, and M. Nichol A checklist for medication compliance and persistence studies using retrospective databases Value Health 10 1 2007 3 12
21. W.L. St Peter, J. Liu, E. Weinhandl, and Q. Fan A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data Am J Kidney Dis 51 3 2008 445 454
22. Kidney Disease: Improving Global Outcomes(KDIGO) CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl 113 2009 S1 S130
23. R.S. Shantouf, M.J. Budoff, and N. Ahmadi et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients Am J Nephrol 31 5 2010 419 425
24. M.J. Budoff, L.J. Shaw, and S.T. Liu et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients J Am Coll Cardiol 49 18 2007 1860 1870
25. Y. Shimoyama, Y. Tsuruta, and T. Niwa Coronary artery calcification score is associated with mortality in Japanese hemodialysis patients J Ren Nutr 22 1 2012 139 142
26. S.H. Simpson, D.T. Eurich, and S.R. Majumdar et al. A meta-analysis of the association between adherence to drug therapy and mortality BMJ 333 7557 2006 15
27. E.S. Johnson, B.A. Bartman, and B.A. Briesacher et al. The incident user design in comparative effectiveness research. Effective Health Care Program Research Report No. 32 2012 Agency for Healthcare Research and Quality Rockville, MD http://effectivehealthcare.ahrq.gov/ehc/products/442/1086/ Decide32-IncidentUserDesign-FinalReport-20120515.pdf Accessed April 29, 2013
28. A.J. Collins, R.N. Foley, and B. Chavers United States Renal Data System 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States Am J Kidney Dis 59 1 suppl 1 2012 e1 e420
29. W.Y. Qunibi, R.E. Hootkins, and L.L. McDowell et al. Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE) Study Kidney Int 65 5 2004 1914 1926
30. T. Isakova, O.M. Gutierrez, and Y. Chang et al. Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2 2009 388 396
31. G.A. Block, D.C. Wheeler, and M.S. Persky et al. Effects of phosphate binders in moderate CKD J Am Soc Nephrol 23 8 2012 1407 1415